Page last updated: 2024-09-02

tadalafil and Dextro-Looped Transposition of the Great Arteries

tadalafil has been researched along with Dextro-Looped Transposition of the Great Arteries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Beitzke, D; Bouchardy, J; Buechel, RR; Engel, R; Freese, M; Frenk, A; Gabriel, H; Greutmann, M; Haaf, P; Heg, D; Mueller, C; Possner, M; Ruperti-Repilado, FJ; Rutz, T; Schwerzmann, M; Schwitter, J; Schwitz, F; Tobler, D; Trachsel, L; Valsangiacomo Buechel, E; Willhelm, M; Wustmann, K1
Bouchardy, J; Buechel, RR; Freese, M; Frenk, A; Gabriel, H; Greutmann, M; Heg, D; Müller, C; Reto, E; Rutz, T; Schwerzmann, M; Schwitter, J; Tobler, D; Trachsel, L; Willhelm, M1

Trials

2 trial(s) available for tadalafil and Dextro-Looped Transposition of the Great Arteries

ArticleYear
Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
    European journal of heart failure, 2023, Volume: 25, Issue:7

    Topics: Adult; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Female; Heart Failure; Heart Ventricles; Humans; Middle Aged; Stroke Volume; Tadalafil; Transposition of Great Vessels; Ventricular Function, Right

2023
Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design.
    International journal of cardiology, 2017, Sep-15, Volume: 243

    Topics: Double-Blind Method; Heart Ventricles; Humans; Phosphodiesterase 5 Inhibitors; Tadalafil; Transposition of Great Vessels; Treatment Outcome; Ventricular Function, Right

2017